Boehringer Ingelheim Announces Several Idiopathic Pulmonary Fibrosis Presentations at Upcoming International Scientific Meeting
Boehringer Ingelheim Pharmaceuticals, Inc. recently announced in a press release that the company will present 29 abstracts on respiratory disorders at the 2015 American Thoracic Society (ATS) International Conference in Denver, May 15-20. The company will present the latest data on their investigational drug portfolio for disorders like chronic…